Tag: Emirates Drug Establishment

UAE becomes second country globally to approve Wegovy pill for weight loss

The UAE has become the second country worldwide to approve the oral…

ME Desk

UAE Strengthens access to innovative care with New Fibrosis Drug Approval

The Emirates Drug Establishment has approved Jascayd® (nerandomilast) for the treatment of…

ME Desk

UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases

The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…

ME Desk

UAE Among First Globally to Approve New Obesity and Hypertension Treatments

The United Arab Emirates is strengthening its global leadership in healthcare innovation…

ME Desk

First locally discovered drug candidate: UAE joins AI-powered drug development race

The UAE has announced its first fully AI-discovered drug candidate, ISM0387, developed…

ME Desk

UAE: Emirates Drug Establishment approves oral obesity treatment

Emirates Drug Establishment, EDE UAE, orforglipron, Foundayo, Eli Lilly, oral obesity treatment,…

ME Desk

UAE pharmaceutical sector stable and strategic medicine stockpile secure, Emirates Drug Establishment confirms

UAE’s pharmaceutical sector remains stable with a secure strategic stockpile, ensuring uninterrupted…

ME Desk

Emirates Drug Establishment Recalls Select Nestlé Infant Formula Batches Across UAE Over Safety Concerns

The Emirates Drug Establishment has initiated a precautionary recall of select Nestlé…

ME Desk

Emirates Drug Establishment Approves Tapinarof Cream 1%

Organon, a global healthcare company with a mission to improve the health…

ME Desk